NiRCOVID Role of nicotinic receptors in the pathogenesis of COVID-19
- Funded by ANR
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19start year
-99Known Financial Commitments (USD)
$0Funder
ANRPrincipal Investigator
Uwe MaskosResearch Location
FranceLead Research Institution
N/AResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Pathogen morphology, shedding & natural history
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
The NiRCOVID project will investigate the hypothesis that the nicotinic acetylcholine receptor (nAChR) is part of the infection process and pulmonary pathology, in particular with regard to the "cytokine storm" seen in severe cases. The project will explore potential treatment options using nicotinic receptor modulators in vitro and in vivo, in mice and human cultures.